LLP — LeanLife Health Cashflow Statement
0.000.00%
Consumer DefensivesSpeculativeMicro Cap
Annual cashflow statement for LeanLife Health, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2017 March 31st | 2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.982 | -2.36 | -2.72 | -2.95 | -3.67 |
| Depreciation | |||||
| Non-Cash Items | 0.092 | 0.547 | 0.461 | 0.64 | 0.962 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.018 | -0.06 | 0.234 | 2 | 1.49 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -0.87 | -1.87 | -2.01 | -0.307 | -1.21 |
| Capital Expenditures | -0.003 | -0.434 | -0.048 | -0.016 | -0.148 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | 0.145 | 0 |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.003 | -0.434 | -0.048 | 0.129 | -0.148 |
| Financing Cash Flow Items | -0.291 | -0.057 | 0.041 | 0.096 | -0.394 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.05 | 2.17 | 2.04 | 0.151 | 1.63 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.18 | -0.133 | -0.02 | -0.026 | 0.263 |